G. Carles et al., THE EFFECT OF COMBINING ANTITUBULIN AGENTS ON DIFFERENTIATED AND UNDIFFERENTIATED HUMAN COLON-CANCER CELLS, Anti-cancer drugs, 9(3), 1998, pp. 209-221
The cytotoxicity of sequential combinations of a taxoid [paclitaxel (T
AX) or docetaxel (TXT)] with a vinca alkaloid [vinorelbine (NVB)] was
compared in differentiated and undifferentiated HT29-D4 cells. Agents
were titrated from low doses inducing no modification of microtubule n
etwork to high doses corresponding to the clinically relevant concentr
ations that block mitosis. For undifferentiated cells, the sequential
combination NVB/TAX was more efficient than TAX/NVB (22% cell survival
versus 37% for 5 nM TAX and NVB). Surprisingly, we successively obtai
ned synergism for low doses of both compounds [NVB (1-5 nM) and TAX (1
- 15 nM)], then additivity and finally antagonism when one of the comp
ounds was at the concentration inducing mitotic block. The three patte
rns of results were also obtained with NVB/TXT combinations. For the s
ynergistic combinations at the lowest concentrations, cytotoxicity occ
urred by apoptosis following mitosis. For differentiated cells, the mo
st cytotoxic combinations were 1 mu M TAX or TXT for 3 days followed b
y 1 mu M NVB for 3 days, and 0.75 nM TAX or TXT for 9 days followed by
1 mu M NVB for 3 days, the latter producing synergistic effects. Cyto
toxicity occurred by apoptosis for the two states of differentiation.
Major differences depending on cell phenotype were demonstrated: low s
ensitivity of differentiated cells to antitubulin agents and the diffe
rence in apoptotic pathways since mitosis is not involved in different
iated cells. [(C) 1998 Rapid Science Ltd.].